Home/Filings/4/0000950170-25-086264
4//SEC Filing

Nichols Weston 4

Accession 0000950170-25-086264

CIK 0001658247other

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 4:30 PM ET

Size

7.3 KB

Accession

0000950170-25-086264

Insider Transaction Report

Form 4
Period: 2025-06-11
Transactions
  • Award

    Stock Option (right to buy)

    2025-06-11+10,35010,350 total
    Exercise: $32.33Exp: 2035-06-11Common Stock (10,350 underlying)
  • Award

    Common Stock

    2025-06-11+6,90016,300 total
Footnotes (2)
  • [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
  • [F2]The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Documents

1 file

Issuer

Crinetics Pharmaceuticals, Inc.

CIK 0001658247

Entity typeother

Related Parties

1
  • filerCIK 0001746376

Filing Metadata

Form type
4
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:30 PM ET
Size
7.3 KB